Alvotech

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$9.15-$18
Market Cap
$3.7B
Shares Short
398,567

Financials

See more
Revenue (12 Mos)
$393.9M
Revenue Growth (YoY)
478.6%
Gross Profit (12 Mos)
$232.5M
Diluted EPS
-$1.85

News

See more

Yahoo Finance • 2 days ago

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.

Yahoo Finance • 2 days ago

Alvotech og Teva tilkynna að sala er hafin í Bandaríkjunum á Selarsdi (ustekinumab-aekn), hliðstæðu við líftæknilyfið Stelara

Yahoo Finance • 5 days ago

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

Yahoo Finance • 5 days ago

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

About

CEO
Mr. Robert Wessman
Address
9, Rue de Bitbourg, Luxembourg, Luxembourg, 1273
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-Time Employees
999